Skip to main content
. 2016 Apr 27;11(4):e0154317. doi: 10.1371/journal.pone.0154317

Fig 5. Level of ARV drug resistance according to each class of reverse transcriptase and protease inhibitors in Panamanian HIV-1 subtype B infected subjects.

Fig 5

A, Level of ARV drug resistance to nucleoside reverse transcriptase inhibitor (NRTI) and non-nucleoside reverse transcriptase inhibitor (NNRTI) in ARV drug-experienced subjects (n = 467). B, Level of ARV drug resistance to nucleoside reverse transcriptase inhibitor (NRTI) and non-nucleoside reverse transcriptase inhibitor (NNRTI) in ARV drug-naïve subjects (n = 250). C, Level of ARV drug resistance to protease inhibitor (PI) in ARV drug-naïve and ARV drug-experienced subjects. *, means frequency of subjects with <3%. Bar colors are according to legend at top.